Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,537 | 22 | 96.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65.00 | 2 | 2.5% |
| Consulting Fee | $30.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,517 | 21 | $0 (2022) |
| Bard Peripheral Vascular, Inc. | $65.00 | 2 | $0 (2020) |
| Medtronic, Inc. | $50.61 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.61 | 1 | Medtronic, Inc. ($20.61) |
| 2022 | $122.63 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($122.63) |
| 2021 | $278.82 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($248.82) |
| 2020 | $536.07 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($471.07) |
| 2019 | $1,091 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,091) |
| 2018 | $583.35 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($583.35) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 03/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.63 | General |
| Category: DIABETES | ||||||
| 08/27/2021 | Medtronic, Inc. | Launcher (Device) | Consulting Fee | Cash or cash equivalent | $30.00 | General |
| Category: Catheters | ||||||
| 05/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.33 | General |
| 04/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.49 | General |
| 11/09/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.83 | General |
| 09/23/2020 | Bard Peripheral Vascular, Inc. | BD Nexiva (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15.00 | General |
| Category: Medical Surgical IV Access | ||||||
| 09/18/2020 | Bard Peripheral Vascular, Inc. | BD Introsyte (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $50.00 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 08/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $108.27 | General |
| 03/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.88 | General |
| 02/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $113.09 | General |
| 12/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: DIABETES | ||||||
| 11/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 07/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 07/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: DIABETES | ||||||
| 05/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.12 | General |
| Category: DIABETES | ||||||
| 04/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.52 | General |
| 03/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $120.37 | General |
| Category: DIABETES | ||||||
| 02/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $99.10 | General |
| Category: DIABETES | ||||||
| 11/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $116.92 | General |
| Category: DIABETES | ||||||
| 10/04/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $86.89 | General |
| 09/17/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.94 | General |
| 08/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $129.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 975 | 1,101 | $75,862 | $20,454 |
| 2022 | 31 | 1,622 | 1,939 | $126,158 | $37,071 |
| 2021 | 28 | 1,342 | 1,539 | $103,007 | $30,349 |
| 2020 | 22 | 1,210 | 1,415 | $103,194 | $30,088 |
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 109 | 113 | $12,969 | $3,628 | 28.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 44 | 45 | $11,138 | $3,090 | 27.7% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 304 | 390 | $9,818 | $2,682 | 27.3% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 26 | 27 | $6,636 | $1,987 | 29.9% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 28 | 30 | $7,108 | $1,919 | 27.0% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 33 | 33 | $4,879 | $1,174 | 24.1% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 32 | 32 | $4,247 | $1,172 | 27.6% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 84 | 89 | $2,610 | $691.76 | 26.5% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 16 | 16 | $2,528 | $665.54 | 26.3% |
| 76700 | Complete ultrasound scan of abdomen | Facility | 2023 | 20 | 21 | $2,350 | $506.28 | 21.5% |
| 70486 | Ct scan of face without contrast | Facility | 2023 | 15 | 15 | $1,729 | $466.15 | 27.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 16 | 16 | $1,524 | $341.44 | 22.4% |
| 72170 | X-ray of pelvis, 1-2 views | Facility | 2023 | 44 | 44 | $1,060 | $286.64 | 27.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 14 | 14 | $1,409 | $278.64 | 19.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 13 | 13 | $797.00 | $190.40 | 23.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Facility | 2023 | 21 | 25 | $652.00 | $170.32 | 26.1% |
| 74018 | X-ray of abdomen, 1 view | Facility | 2023 | 21 | 25 | $627.56 | $163.44 | 26.0% |
| 73502 | X-ray of hip, 2-3 views | Facility | 2023 | 15 | 19 | $577.88 | $162.91 | 28.2% |
| 73560 | X-ray of knee, 1-2 views | Facility | 2023 | 17 | 19 | $437.00 | $137.10 | 31.4% |
| 73552 | X-ray of thigh bone, minimum 2 views | Facility | 2023 | 17 | 19 | $475.00 | $132.08 | 27.8% |
| 73610 | X-ray of ankle, minimum of 3 views | Facility | 2023 | 18 | 20 | $481.13 | $127.47 | 26.5% |
| 73562 | X-ray of knee, 3 views | Facility | 2023 | 14 | 16 | $416.00 | $113.76 | 27.3% |
| 73630 | X-ray of foot, minimum of 3 views | Facility | 2023 | 16 | 18 | $415.00 | $107.40 | 25.9% |
| 73130 | X-ray of hand, minimum of 3 views | Facility | 2023 | 12 | 13 | $313.00 | $89.88 | 28.7% |
| 73590 | X-ray of lower leg, 2 views | Facility | 2023 | 14 | 16 | $353.18 | $89.44 | 25.3% |
About Dr. Igor Fishkin, MD
Dr. Igor Fishkin, MD is a Diagnostic Ultrasound healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225108673.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Igor Fishkin, MD has received a total of $2,632 in payments from pharmaceutical and medical device companies, with $20.61 received in 2024. These payments were reported across 25 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($2,537).
As a Medicare-enrolled provider, Fishkin has provided services to 5,149 Medicare beneficiaries, totaling 5,994 services with total Medicare billing of $117,962. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Ultrasound
- Other Specialties Vascular & Interventional Radiology
- Location Brooklyn, NY
- Active Since 11/09/2006
- Last Updated 10/18/2018
- Taxonomy Code 2085U0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225108673
Products in Payments
- JARDIANCE (Drug) $955.84
- OFEV (Drug) $125.00
- BD Introsyte (Device) $50.00
- Launcher (Device) $30.00
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $20.61
- BD Nexiva (Device) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.